Targeting the Dopaminergic Pathway: Evolving Approaches in Parkinson Disease
Please check back later for more content.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Issues Complete Response Letter for Spinocerebellar Ataxia Agent Troriluzole
2
Dental Caries and Periodontal Disease Increase Ischemic Stroke Risk, Study Shows
3
FDA Feedback Provides Clarity for Phase 3 Trial of Neflamapimod in Dementia With Lewy Bodies
4
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
5
